Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02986360 · ClinicalTrials.gov registry record · NA

Informed Implementation of Breast Density Reporting

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
500
Enrollment target

NCT02986360: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT02986360 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02986360, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target

Study Summary

1. To develop brief informational videos, Vidscrips, that can be sent to women following their mammogram to provide personalized information that integrates breast density with overall breast cancer risk, and provides information about additional care recommendations and talking tips for conversations with the health care providers. 2. To test the effectiveness of this tool in a trial of 300 women undergoing mammography. The investigators hypothesize that individuals in the intervention arm (vs. those in the standard care arm who receive a letter with the language required by the legislation) will have more accurate knowledge of their overall risk of breast cancer, their Mammographic Breast Density (MBD) result, more appropriate observed and intended use of additional screening \[i.e., use of screening Magnetic Resonance Imaging (MRI) will be reserved only for women at high risk of breast cancer\], better satisfaction with their episode of breast cancer screening, less decisional conflict about their personal decision for any additional evaluation, and less worry about breast cancer.

Primary Outcome

electronic questionnaire developed by research staff

Interventions

  • BEHAVIORAL Vidscrip educational video

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-05-01
Est. Completion 2017-11-30
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT02986360 record still lists

NCT02986360 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 1 intervention - of which Vidscrip educational video is the first listed.

NCT02986360 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02986360 about?

NCT02986360 is a clinical study titled "Informed Implementation of Breast Density Reporting". 1. To develop brief informational videos, Vidscrips, that can be sent to women following their mammogram to provide personalized information that integrates breast density with overall breast cancer risk, and provides information about additional care recommendations and talking tips for conversatio...

What is the current status of trial NCT02986360?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2017-05-01. Estimated completion is 2017-11-30.

What interventions are being tested in trial NCT02986360?

The interventions under investigation include: Vidscrip educational video (BEHAVIORAL).

Who is sponsoring clinical trial NCT02986360?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02986360's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02986360, the US trial registry maintained by the National Library of Medicine. NCT02986360 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.